doi:10.3181/0703-MR-67
Morgan Research forecasts patients on GLP-1s could exceed 30 million in the U.S
Beyond weight loss, semaglutide GLP-1 can have positive effects on overall health
Stanton EW, Manasyan A, Banerjee R, Hong K, Koesters E, Daar DA
We may disclose information to regulators, law enforcement, courts, payment providers, carriers, or other parties when reasonably necessary to comply with law, protect rights or safety, investigate misuse, or enforce these Terms
Can commit to ongoing subscription costs: At price points in the $249-$299/month range (based on current platform disclosures), the financial commitment is significant and ongoing